1 / 3

Nelfinavir

Boc Sciences offers 159989-64-7 Nelfinavir in bulk, please inquire us to get a quote for 159989-64-7 Nelfinavir.<br>https://www.bocsci.com/nelfinavir-cas-159989-64-7-item-84-455040.html<br>

bocsci2018
Télécharger la présentation

Nelfinavir

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nelfinavir - CAS 159989-64-7 An HIV-1 protease inhibitor. It inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles. Please be kindly noted that our product can only be used for research to orgnizations or companies and we don't cooperate with personal buyers. Category Inhibitor Targets HIV SARS-CoV-2 Molecular Formula C32H45N3O4S Molecular Weight 567.78 Chemical Information Category Inhibitor Molecular Formula C32H45N3O4S Molecular Weight 567.78

  2. Specification Properties Reference Reading Purity Purity ≥98% Related CAS Related CAS 159989-65-8 (Mesylate) Synonyms Synonyms Viracept; AG 1341; AG-1341; AG1341 Clinical Trial Information NCT Number NCT Number Title Title Condition Or Condition Or Disease Disease Phase Phase Start Start Date Date Sponsor Sponsor Status Status NCT00023400 TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB HIV Infections Phase 4 February 2000 Centers for Disease Control and Prevention Completed NCT00099359 Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission Disease Transmission, Vertical Phase 3 February 2004 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Completed NCT00122590 Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART) HIV Infections July 2002 French National Agency for Research on AIDS and Viral Hepatitis Terminated

  3. NCT00192660 HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001) HIV- Associated Lipodystrophy Syndrome Phase 4 February 2003 Kirby Institute Completed NCT00205283 Nelfinavir and M8 Drug- level Monitoring in HIV-1 Infection HIV Infections August 2003 University of Wisconsin, Madison Unknown status Publication citing BOC Sciences Products Bio Calculators Solution Dilution Calculator Molecular Weight Calculator Molarity Calculator Stock concentration: *    molar (M) Desired final volume: * liters (L) Desired concentration: * molar (M) L * Our calculator is based on the following equation: Concentration (start) x Volume (start) = Concentration (final) x Volume (final) It is commonly abbreviated as: C1V1 = C2V2 https://www.bocsci.com/nelfinavir-cas-159989-64-7-item-84-455040.html

More Related